ARS Pharmaceuticals, Inc. (SPRY) Net income

annual net income:

$8.00M+$62.36M(+114.71%)
December 31, 2024

Summary

  • As of today (September 13, 2025), SPRY annual net profit is $8.00 million, with the most recent change of +$62.36 million (+114.71%) on December 31, 2024.
  • During the last 3 years, SPRY annual net income has risen by +$28.24 million (+139.51%).
  • SPRY annual net income is now at all-time high.

Performance

SPRY Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYincome statement metrics

quarterly net income:

-$44.88M-$10.94M(-32.24%)
June 30, 2025

Summary

  • As of today (September 13, 2025), SPRY quarterly net profit is -$44.88 million, with the most recent change of -$10.94 million (-32.24%) on June 30, 2025.
  • Over the past year, SPRY quarterly net income has dropped by -$32.37 million (-258.60%).
  • SPRY quarterly net income is now -189.88% below its all-time high of $49.93 million, reached on December 31, 2024.

Performance

SPRY quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYincome statement metrics

TTM net income:

-$48.02M-$32.37M(-206.82%)
June 30, 2025

Summary

  • As of today (September 13, 2025), SPRY TTM net profit is -$48.02 million, with the most recent change of -$32.37 million (-206.82%) on June 30, 2025.
  • Over the past year, SPRY TTM net income has dropped by -$3.17 million (-7.08%).
  • SPRY TTM net income is now -700.36% below its all-time high of $8.00 million, reached on December 31, 2024.

Performance

SPRY TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SPRY Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+114.7%-258.6%-7.1%
3 y3 years+139.5%-599.1%+19.7%
5 y5 years+133.4%-594.0%-156.6%

SPRY Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+114.7%-189.9%at low-700.4%+11.7%
5 y5-yearat high+114.7%-189.9%at low-700.4%+46.3%
alltimeall timeat high+114.7%-189.9%at low-700.4%+46.3%

SPRY Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$44.88M(+32.2%)
-$48.02M(+206.8%)
Mar 2025
-
-$33.94M(-168.0%)
-$15.65M(-295.7%)
Dec 2024
$8.00M(-114.7%)
$49.93M(-361.1%)
$8.00M(-116.3%)
Sep 2024
-
-$19.13M(+52.8%)
-$49.10M(+9.5%)
Jun 2024
-
-$12.52M(+21.6%)
-$44.84M(-9.8%)
Mar 2024
-
-$10.29M(+43.6%)
-$49.70M(-8.6%)
Dec 2023
-$54.37M(+56.8%)
-$7.17M(-51.8%)
-$54.37M(+15.2%)
Sep 2023
-
-$14.87M(-14.4%)
-$47.20M(+21.3%)
Jun 2023
-
-$17.37M(+16.1%)
-$38.91M(+39.2%)
Mar 2023
-
-$14.96M(+127.3%)
-$27.96M(-36.0%)
Dec 2022
-$34.68M
-
-
Sep 2022
-
-$6.58M(+2.5%)
-$43.71M(-26.9%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$6.42M(-11.4%)
-$59.78M(-23.2%)
Mar 2022
-
-$7.25M(-69.1%)
-$77.86M(-13.0%)
Dec 2021
-$20.24M(-38.6%)
-
-
Dec 2021
-
-$23.46M(+3.6%)
-$89.48M(+13.1%)
Sep 2021
-
-$22.66M(-7.5%)
-$79.10M(+40.1%)
Jun 2021
-
-$24.50M(+29.8%)
-$56.45M(+46.9%)
Mar 2021
-
-$18.87M(+44.2%)
-$38.42M(+54.7%)
Dec 2020
-$32.95M(+37.5%)
-$13.09M(+102.3%)
-$24.83M(+32.7%)
Jun 2020
-
-$6.47M(+22.5%)
-$18.72M(+52.8%)
Mar 2020
-
-$5.28M(-24.3%)
-$12.25M(+75.7%)
Dec 2019
-$23.97M(+36.3%)
-$6.97M
-$6.97M
Dec 2018
-$17.58M
-
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual net profit?
  • What is the all time high annual net income for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly net profit?
  • What is the all time high quarterly net income for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is ARS Pharmaceuticals, Inc. TTM net profit?
  • What is the all time high TTM net income for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. TTM net income year-on-year change?

What is ARS Pharmaceuticals, Inc. annual net profit?

The current annual net income of SPRY is $8.00M

What is the all time high annual net income for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual net profit is $8.00M

What is ARS Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, SPRY annual net profit has changed by +$62.36M (+114.71%)

What is ARS Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of SPRY is -$44.88M

What is the all time high quarterly net income for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly net profit is $49.93M

What is ARS Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, SPRY quarterly net profit has changed by -$32.37M (-258.60%)

What is ARS Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of SPRY is -$48.02M

What is the all time high TTM net income for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high TTM net profit is $8.00M

What is ARS Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, SPRY TTM net profit has changed by -$3.17M (-7.08%)
On this page